Published in Obesity and Diabetes Week, April 18th, 2005
The assets sold include the company's intellectual property; product development and production equipment; regulatory package; inventory and certain assumed contracts, including all supplier, manufacturing, and license agreements relating to the company's glucose monitoring technology and GlucoWatch Biographer line of products. The asset sale...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.